Skip to main content

Table 3 Baseline study sample characteristics of e-cigarette (EC) group

From: “It is the One Thing that has Worked”: facilitators and barriers to switching to nicotine salt pod system e-cigarettes among African American and Latinx people who smoke: a content analysis

Variable

All

Race/ethnicity

Tobacco use trajectory

Mean (SD) or N (%)

Mean (SD) or N (%)

Mean (SD) or N (%)

N = 114

African American

n = 60

Latinx

n = 54

Exclusive EC use

n = 32

Dual EC and cigarette use

n = 66

Continued cigarette use

n = 16

Age

44.6 (12.9)

51.4 (9.4)

37.1 (12.1)

44.4 (13.8)

43.9 (13.0)

48.0 (10.6)

Sex, % female

46 (40.4)

32 (53.3)

14 (25.9)

16 (50.0)

25 (37.9)

5 (31.3)

African American

60 (52.6)

  

16 (50.0)

35 (53.0)

9 (56.3)

Latinx

54 (47.4)

  

16 (50.0)

31 (47.0)

7 (43.8)

Education, ≤ high school

63 (55.3)

36 (60.0)

27 (50.0)

21 (65.6)

33 (50.0)

9 (56.3)

Income, ≤ 200% federal poverty level

83 (74.1)f

47 (81.0)f

36 (66.7)

21 (65.6)

50 (76.9)g

12 (80.0)g

Marital status, never married

51 (44.7)

28 (46.7)

23 (42.6)

10 (31.3)

32 (48.5)

9 (56.3)

Menthol use, % yes

64 (56.1)

48 (80.0)

16 (29.6)

18 (56.3)

36 (54.5)

10 (62.5)

Number years smoking

17.3 (13.1)

19.3 (13.7)

15.0 (12.1)

13.6 (12.0)

16.8 (12.0)

26.7 (15.8)

Time to first cigarette ≤ 30 min

81 (71.1)

43 (71.7)

38 (70.4)

22 (68.8)

47 (71.2)

12 (75.0)

Days smoked/past 7a

6.8 (0.5)

6.8 (0.6)

6.9 (0.4)

6.8 (0.4)

6.9 (0.5)

6.8 (0.5)

Cigarettes per day/past 7a

12.4 (7.9)

12.3 (7.9)

12.5 (8.1)

11.2 (5.5)

12.4 (7.9)

14.7 (11.5)

Days used EC/past 7a

0.04 (0.30)

0.00 (0.00)

0.07 (0.43)

0.00 (0.00)

0.06 (0.39)

0.00 (0.00)

EC times on days used/past 7a

0.06 (0.51)

0.00 (0.00)

0.12 (0.74)

0.00 (0.00)

0.10 (0.67)

0.00 (0.00)

Past-year quit attempt, % yesb

37 (32.5)

18 (30.0)

19 (35.2)

13 (40.6)

19 (28.8)

5 (31.3)

 Relied on friend/family support, % yes

8 (21.6)

4 (22.2)

4 (21.1)

1 (7.7)

5 (26.3)

2 (40.0)

 Used counseling or other support resources, % yesc

11 (30.6)g

6 (35.3)g

5 (26.3)

2 (15.4)

8 (44.4)g

1 (20.0)

 Used nicotine patch, gum, inhaler, nasal spray, lozenge or pill, % yes

7 (18.9)

2 (11.1)

5 (26.3)

2 (15.4)

3 (15.8)

2 (40.0)

 Used Chantix (varenicline) or Zyban (Wellbutrin or bupropion), % yes

4 (10.8)

4 (22.2)

0 (0)

0 (0)

3 (15.8)

1 (20.0)

 Used a different tobacco product, % yesd

6 (16.2)

0 (0)

6 (31.6)

2 (15.4)

4 (21.1)

0 (0)

History of chronic obstructive pulmonary disease, % yes

10 (8.8)g

7 (11.9)g

3 (5.6)

4 (12.9)g

4 (6.1)

2 (12.5)

History of asthma, % yes

29 (25.7)g

17 (28.8)g

12 (22.2)

7 (22.6)g

18 (27.3)

4 (25.0)

Mental health history, % any historye

72 (63.2)

40 (66.7)

32 (59.3)

21 (65.6)

40 (60.6)

11 (68.8)

History of substance abuse, % yes

58 (50.9)

29 (48.3)

29 (53.7)

15 (46.9)

32 (48.5)

11 (68.8)

  1. Table displays baseline study sample characteristics of the EC group. Variables are reported for all, split by race/ethnicity, and split by tobacco use trajectory
  2. aFrom 7-day timeline follow-back
  3. bDenominator for quit attempt strategies
  4. cOther support resources include a telephone help line or quit line, books, pamphlets, videos, a quit tobacco clinic, class, or support group, and internet or web-based programs
  5. dDifferent tobacco products include e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe tobacco, hookah, snus pouches, smokeless tobacco (dip, chew, snuff), and dissolvable tobacco
  6. eSelf-reported history of depression, anxiety, PTSD, or schizophrenia
  7. fTwo values missing
  8. gOne value missing